Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine
NCT04654416 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 301
Last updated 2020-12-04
Summary
Cross sectional study of 301 adult patients with Covid-19 Pneumonia treated with corticosteroid and/or colchicine
Conditions
Interventions
- DRUG
-
Corticosteroid with or without colchicine
We describe the clinical outcome of patients treated with corticosteroid and colchicine
Sponsors & Collaborators
-
Clínica Medellín - Grupo Quirónsalud
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-20
- Primary Completion
- 2020-08-07
- Completion
- 2020-08-20
Countries
- Colombia
Study Locations
More Related Trials
-
Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury
NCT04341038 ·Status: UNKNOWN ·Phase: PHASE3
-
Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia
NCT04540926 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression
NCT04345445 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia
NCT04359511 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients
NCT04673162 ·Status: COMPLETED ·Phase: PHASE3
-
Glucocorticoids in COVID-19 (CORTIVID)
NCT04438980 ·Status: COMPLETED ·Phase: PHASE3
-
Predictive Factors COVID-19 Patients
NCT04427345 ·Status: WITHDRAWN
-
Corticosteroids for COVID-19
NCT04795583 ·Status: WITHDRAWN ·Phase: PHASE3
-
Early Short Course Corticosteroids in COVID-19
NCT04374071 ·Status: COMPLETED
-
Steroid and Anticoagulant Therapy in covid19
NCT05021588 ·Status: COMPLETED ·Phase: NA
-
Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2
NCT05293210 ·Status: UNKNOWN ·Phase: PHASE3
-
Corticoids in Severe Community-Acquired Pneumonia (CAP)
NCT00908713 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia
NCT04329650 ·Status: COMPLETED ·Phase: PHASE2
-
Characteristics of Patients With COVID-19 in Meta State, Colombia
NCT04456426 ·Status: WITHDRAWN
-
Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19
NCT04505709 ·Status: UNKNOWN
-
Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19
NCT04534478 ·Status: UNKNOWN ·Phase: PHASE4
-
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
NCT04344288 ·Status: TERMINATED ·Phase: PHASE2
-
The Natural History of Hospitalized COVID-19 Patients
NCT04424992 ·Status: RECRUITING
-
Efficacy of Early Administration of Tocilizumab in COVID-19 Patients
NCT04346355 ·Status: TERMINATED ·Phase: PHASE2
-
Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19
NCT04953247 ·Status: COMPLETED
-
Corticosteroids in Community Acquired Pneumonia
NCT04652414 ·Status: WITHDRAWN ·Phase: PHASE2
-
Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain
NCT04355871 ·Status: COMPLETED
-
Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, with CoViD-19
NCT04765371 ·Status: COMPLETED ·Phase: PHASE3
-
Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia
NCT04887246 ·Status: COMPLETED
-
Colchicine Counteracting Inflammation in COVID-19 Pneumonia
NCT04322565 ·Status: COMPLETED ·Phase: PHASE2